dipyridamole has been researched along with 3-(6-isobutyl-9-methoxy-1,4-dioxo-1,2,3,4,6,7,12,12a-octahydropyrazino(1',2'-1,6)pyrido(3,4-b)indol-3-yl)propionic acid tert-butyl ester in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gao, H; Gonzalez, FJ; Hong, X; Krausz, KW; Li, S; Qin, Z; Wu, B; Yao, X; Yao, Z | 1 |
1 other study(ies) available for dipyridamole and 3-(6-isobutyl-9-methoxy-1,4-dioxo-1,2,3,4,6,7,12,12a-octahydropyrazino(1',2'-1,6)pyrido(3,4-b)indol-3-yl)propionic acid tert-butyl ester
| Article | Year |
|---|---|
Chemical inhibition and stable knock-down of efflux transporters leads to reduced glucuronidation of wushanicaritin in UGT1A1-overexpressing HeLa cells: the role of breast cancer resistance protein (BCRP) and multidrug resistance-associated proteins (MRPs
Topics: ATP Binding Cassette Transporter, Subfamily G, Member 2; Biological Transport; Diketopiperazines; Dipyridamole; Drugs, Chinese Herbal; Epimedium; Flavonoids; Gene Knockdown Techniques; Gene Silencing; Glucuronides; Glucuronosyltransferase; HeLa Cells; Heterocyclic Compounds, 4 or More Rings; Humans; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Propionates; Quinolines; RNA, Small Interfering | 2018 |